Genmab A (GMAB) Assets (2023 - 2026)
Genmab A (GMAB) reported Assets of $12.52 billion for the quarter ended Jun 30, 2026, up 1.1% from the prior quarter.
Analysis
Genmab A (GMAB) Assets (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A posted Assets of $12.87 billion, up 100.7% from the prior year.
- Assets has increased for seven consecutive years, with a five-year compound annual growth rate of 39.3% (years ended Dec 2020 to Dec 2025).
- By year, Assets came in at $6.41 billion in the year ended Dec 31, 2024 (+22.6%), $5.23 billion in the year ended Dec 31, 2023 (+86.2%), $2.81 billion in the year ended Dec 31, 2022 (+1.0%) and $2.78 billion in the year ended Dec 31, 2021 (+13.3%).
- Five-year quarterly Assets spans a low of $904.2 million in the quarter ended Sep 30, 2025 and a high of $12.87 billion in the quarter ended Dec 31, 2025.
- Year over year, Assets gained in three of the last four quarters, with growth averaging 56.1%.
- The high point for year-over-year Assets in five years was the quarter ended Dec 31, 2025 (growth of 202.0%); the low point was the quarter ended Sep 30, 2021 (a decline of 87.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.99 Bn | 1,139.58 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 642.25 Bn | 560.77 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 502.08 Bn | 475.19 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 375.61 Bn | 329.99 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.76 Bn | 266.75 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 268.66 Bn | 242.35 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.98 Bn | 197.38 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.37 Bn | 167.57 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Genmab A | 2.59 Bn | -2.78 Bn | 1.07 Bn | 12.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Bn |
| Mar 31, 2026 | 12.38 Bn |
| Dec 31, 2025 | 12.87 Bn |
| Sep 30, 2025 | 904.20 Mn |
| Jun 30, 2025 | 6.46 Bn |
| Mar 31, 2025 | 6.59 Bn |
| Dec 31, 2024 | 6.41 Bn |
| Dec 31, 2023 | 5.23 Bn |
| Jan 1, 2023 | 4.32 Bn |
API Access
Genmab A Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();